First Affiliated Hospital of Wenzhou Medical University
239
67
78
24
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.3%
3 terminated/withdrawn out of 239 trials
88.9%
+2.3% vs industry average
14%
33 trials in Phase 3/4
0%
0 of 24 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (239)
Postbiotics for GI Recovery After Malignant Bowel Obstruction Surgery
Role: lead
Application of Precision Partial Intersphincteric Resection (PPISR)
Role: lead
Anesthesia and Perioperative Neurocognitive Disorders in the Elderly Patients Undergoing Hip Fracture Surgery Platform Trial (ANDES Platform Trial)
Role: collaborator
BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma
Role: collaborator
Entacapone Plus Bevacizumab for Glioblastoma at First Recurrence
Role: lead
Lenvatinib Plus Tislelizumab With or Without Gefitinib for Advanced Liver Cancer
Role: lead
Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia
Role: lead
Safety and Efficacy Evaluation of Single-Port Versus Multi-Port Robotic-Assisted Radical Distal Gastrectomy for Gastric Cancer
Role: lead
Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography
Role: lead
Multicenter Clinical Study on the Efficacy and Esthetic Outcomes of Immediate Implant Placement Using the Socket-Shield Technique Versus Conventional Immediate Implantation in the Anterior Maxillary Esthetic Zone
Role: lead
Preoperative Nasal Intestinal Obstruction Catheter Mediated Terminal Ileum Fecal Diversion Versus Intraoperative Protective Ileostomy for Preventing Anastomotic Leakage After Mid Low Rectal Cancer Surgery: A Non Inferiority, Prospective, Multicenter Randomized Controlled Trial
Role: lead
Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
Role: collaborator
Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy
Role: lead
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
Role: lead
FFR Versus IVUS With Angiography-Derived FFR for Clinical Outcomes in Patients With Coronary Artery Disease
Role: collaborator
Research on Aneurysm Growth Prediction in Vascular Dilation Caused by Bicuspid Aortic Valve Based on VDM and CFD
Role: collaborator
Research on Predicting Aortic Remodeling Following TEVAR for Type B Aortic Dissection Based on VDM and CFD
Role: collaborator
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
Role: collaborator
PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer
Role: collaborator
Coronary Crossing System in Patients With Coronary Chronic Total Occlusions
Role: collaborator